Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
144.88B
Market cap144.88B
Price-Earnings ratio
19.19
Price-Earnings ratio19.19
Dividend yield
6.87%
Dividend yield6.87%
Average volume
36.95M
Average volume36.95M
High today
$25.64
High today$25.64
Low today
$24.70
Low today$24.70
Open price
$25.02
Open price$25.02
Volume
61.34M
Volume61.34M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.40
52 Week low$23.40

Stock Snapshot

The current Pfizer(PFE) stock price is $25.35, with a market capitalization of 144.88B. The stock trades at a price-to-earnings (P/E) ratio of 19.19 and offers a dividend yield of 6.87%.

On 2026-08-04, Pfizer(PFE) stock traded between a low of $24.70 and a high of $25.64. Shares are currently priced at $25.35, which is +2.6% above the low and -1.1% below the high.

The Pfizer(PFE)'s current trading volume is 61.34M, compared to an average daily volume of 36.95M.

During the past year, Pfizer(PFE) stock moved between $23.40 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.40 at its lowest and $28.75 at its peak.

PFE News

Benzinga 5h
Pfizer's Diversified Drug Portfolio Fuels Growth as COVID Sales Decline

Pfizer Beats Estimates, Lifts Revenue Outlook Chairman and CEO Albert Bourla said the company’s launched and acquired products continued to perform well, its o...

Pfizer's Diversified Drug Portfolio Fuels Growth as COVID Sales Decline
Benzinga 5h
What's Going on With Pfizer Stock Tuesday? - Pfizer - Benzinga

...

What's Going on With Pfizer Stock Tuesday? - Pfizer - Benzinga
TipRanks 6h
Cboe data shows mixed options sentiment in Pfizer with shares up 2.3%

Cboe data shows mixed options sentiment in Pfizer (PFE), with shares up 57c, or 2.3%, near $25.61. Options volume running well above average with 105k contracts...

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Nasdaq 6h
PFE Q2 Earnings Top, 2026 Sales View Tweaked, COVID Forecast Cut

Pfizer PFE reported second-quarter 2026 adjusted earnings per share of 77 cents, which beat the Zacks Consensus Estimate of 68 cents per share. Earnings were fl...

PFE Q2 Earnings Top, 2026 Sales View Tweaked, COVID Forecast Cut
Benzinga 8h
Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 700 points on Tuesday. Following the market opening Tuesday, the Dow traded u...

Dow Jumps Over 700 Points; Pfizer Posts Upbeat Q2 Earnings
Nasdaq 9h
Pfizer Q2 26 Earnings Conference Call At 10:00 AM ET

(RTTNews) - Pfizer Inc. (PFE) will host a conference call at 10:00 AM ET on August 4, 2026, to discuss Q2 26 earnings results. To access the live webcast, log...

Pfizer Q2 26 Earnings Conference Call At 10:00 AM ET
Simply Wall St 9h
Is Pfizer A Bargain Following Its Earnings Beat And 2026 Guidance Lift?

Pfizer (PFE) is back in focus after reporting a second quarter earnings beat, raising its 2026 revenue guidance midpoint by US$500 million, and highlighting new...

Is Pfizer A Bargain Following Its Earnings Beat And 2026 Guidance Lift?
Seeking Alpha 10h
Pfizer tops Q2 expectations, boosts revenue guidance

Pfizer (NYSE: PFE) reported second-quarter results that topped Wall Street expectations and raised its full-year revenue outlook, driven by stronger-than-expect...

Pfizer tops Q2 expectations, boosts revenue guidance
The Wall Street Journal 10h
Pfizer Post Loss on Higher Revenue

Pfizer swung to a second-quarter loss. angela weiss / Agence France-Presse / Getty Images Pfizer PFE 0.08 %increase; up pointing triangle swung to a second-qua...

Pfizer Post Loss on Higher Revenue
CNBC 10h
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Pfizer Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, March 4, 2026. Pfizer on Tuesday reported second-quarter...

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.